Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

Bayer completes acquisition of Perfuse Therapeutics in a definitive $2.45 billion ophthalmology expansion

18/06/2026 Published by Pharma Biz

Global life science giant Bayer has officially finalized its corporate acquisition of biopharmaceutical enterprise Perfuse Therapeutics, Inc. Following the completion... Read more

Tags: #M&A

U.S. Health Department rolls out over $700 million package targeting mental health, substance addiction, and homelessness

18/06/2026 Published by Pharma Biz

United States Health Secretary Robert F. Kennedy Jr. has officially unveiled a comprehensive institutional funding package exceeding $700 million. The... Read more

Category: Uncategorized

Tags: #Global Trends

Objecting plaintiffs file appeal against regulatory ruling on Bayer’s Roundup class-action settlement

18/06/2026 Published by Pharma Biz

Objecting plaintiffs have formally filed a notice of appeal on Wednesday challenging the judicial decision issued by Judge Autrey. The... Read more

Category: Uncategorized

Tags: #Global Trends

Biogen targets immunology expansion with $1 billion buyout of RayThera

18/06/2026 Published by Pharma Biz

U.S.-listed biopharmaceutical enterprise Biogen Inc. has struck a definitive agreement to acquire privately-held biotechnology firm RayThera in a transaction valued... Read more

Category: Uncategorized

Tags: #M&A

GSK and Spero secure regulatory greenlight for Utebzi, the first oral carbapenem antibiotic for complicated UTIs

18/06/2026 Published by Pharma Biz

Four years after sustaining a regulatory rejection in 2022, British pharmaceutical giant GSK and its partner Spero Therapeutics have scored... Read more

Category: Uncategorized

Tags: #Global Trends